Grafa
Integrated Research expects revenue drop to $56M–$58M
Image for illustrative purposes only. Not a real photo.

Integrated Research expects revenue drop to $56M–$58M

Share
  • Integrated Research released its FY26 trading update showing statutory revenue declining to $56–58 million due to a softer renewals book.
  • Cash reserves increased 27% to $51.7 million despite lower earnings and contract delays.
  • The software provider is pursuing a product-led growth strategy to drive new business and offset customer churn.

Integrated Research (ASX:IRI) reported its FY26 trading update showing full-year statutory revenue is projected between $58 million, down 17% at the midpoint compared to FY25.

The revenue decline reflects a softer renewals book and lower second-half new business contributions alongside deferred contract opportunities.

"FY26 was a pivotal year as IR advanced its product-led growth execution, strengthening innovation, product delivery and client engagement despite challenging financial performance," said Integrated Research CEO and Managing Director Ian Lowe.

Earnings were also impacted by increased expected credit losses and foreign exchange losses, though cash reserves grew to $51.7 million.

Following the announcement, the Integrated Research share price was unchanged at $0.29.

The technology firm designs and sells software designed to monitor performance across business-critical computing networks.

The business is focusing on accelerating the monetisation of new products to deliver sustainable revenue growth over the medium term.

Frequently asked questions

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.